The largest US pharmaceutical company has completed a series of studies in the search for drugs aimed at treating Alzheimer’s and Parkinson’s disease. Clinical tests have not yielded any results, that is why Pfizer had to cut more than 300 employees in order to recover the spent investments. The company also stopped financing the research aimed to find cure for osteoarthritis and fibromyalgia.
The negative news affected the value of Pfizer shares, which fell by 1,11% and continues to extensively go down. It gives a good opportunity to earn money. Let us recall, the asset will be available for trading during the American session, from 14:40 to 21:00 GMT.
The information and recommendations contained in this analytical document are published strictly for information purposes and are not considered as an offer to buy or sell the trading tools mentioned above and are not intended to motivate to perform certain transactions